Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Research Article

    Prevention of Liver Injury by Moringa oleifera aqueous leaf extract in rats treated with isoniazid and rifampicin

    wadmin1By wadmin1July 1, 2012Updated:August 7, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Bello, Balaraba1 and Wudil, A. Muhammad2

    1Nigerian Institute for Trypanosomiasis Research (NITR), Kaduna, Nigeria.

    2Bayero University, Kano, Nigeria.

    Pharmacognosy Communications,2012,2,3,22-25
    DOI: 10.5530/pc.2012.3.5
    Published:July 2012
    Type: Research Article

    ABSTRACT

    Background: Moringa oleifera has been reported to have a lot of therapeutic potential such as antidiabetic, hypocholesterolemic and hypotensive. Objective: This work was undertaken to study the effects of pretreatment and co-administration of aqueous extract of Moringa oleifera leaves on anti-tubercular drug hepatotoxicity in rats. Materials and Methods: Wistar albino rats were divided into six groups of three rats each. Group A was normal control. Group B was the test control administered with anti-tubercular drugs isoniazid (27 mg/kg bw) and rifampicin (54 mg/kg bw) to induce liver damage. Groups C and D were pretreated with 100 mg/kg bw and 200 mg/kg bw of the extract for four weeks, then administered with isoniazid and rifampicin at doses 27 mg/kg bw and 54 mg/kg bw, respectively for same duration. Groups E and F were administered with the same doses of the extracts and anti‑tubercular drugs concurrently for four weeks. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and unconjugated bilirubin (uBIL) were analysed to determine the effect of the extract on hepatotoxicity caused by the drugs. Results: Oral pretreatment and co-administration of aqueous extract of Moringa oleifera leaves significantly (P ≤ 0.05) reduced serum ALT, AST and ALP activities, and uBIL concentration compared to the test control. Conclusion: The results suggest the potential protective effect of aqueous extract of Moringa oleifera on anti-tubercular drug hepatotoxicity in rats.

    Key words: hepatotoxicity, isoniazid, liver damage, Moringa oleifera, rifampicin

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up